These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31347376)

  • 1. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children.
    Peariso K; Arya R; Glauser T; Abend NS; Barcia Aguilar C; Amengual-Gual M; Anderson A; Appavu BL; Brenton JN; Carpenter J; Chapman KE; Clark J; Gaillard WD; Gaínza-Lein M; Goldstein J; Goodkin H; Grinspan Z; Guerriero RM; Horn PS; Huh L; Kahoud R; Kelley SA; Kossoff EH; Kapur K; Lai YC; Marquis BO; McDonough T; Mikati MA; Morgan L; Novotny E; Ostendorf AP; Payne ET; Piantino J; Riviello J; Sands T; Stafstrom CE; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2023 Aug; 101(5):e546-e557. PubMed ID: 37295955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
    Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W
    Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile and outcome of refractory convulsive status epilepticus in older children from a developing country.
    Lingappa L; Konanki R; Patel R; Vooturi S; Jayalakshmi S
    Seizure; 2016 Mar; 36():31-35. PubMed ID: 26889778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much refractory is 'refractory status epilepticus'? A retrospective study of treatment strategies and clinical outcomes.
    Lattanzi S; Giovannini G; Orlandi N; Brigo F; Trinka E; Meletti S
    J Neurol; 2023 Dec; 270(12):6133-6140. PubMed ID: 37587268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line medication dosing in pediatric refractory status epilepticus.
    Vasquez A; Gaínza-Lein M; Abend NS; Amengual-Gual M; Anderson A; Arya R; Brenton JN; Carpenter JL; Chapman K; Clark J; Farias-Moeller R; Gaillard WD; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Kapur K; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf AP; Payne ET; Peariso K; Piantino J; Riviello JJ; Sannagowdara K; Tasker RC; Tchapyjnikov D; Topjian A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2020 Nov; 95(19):e2683-e2696. PubMed ID: 32913024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Abend NS; Anderson AE; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Helseth AR; Jackson MC; Kapur K; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello JJ; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2018 May; 90(19):e1692-e1701. PubMed ID: 29643084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy.
    Jayalakshmi S; Vooturi S; Sahu S; Yada PK; Mohandas S
    J Clin Neurosci; 2016 Apr; 26():89-94. PubMed ID: 26822381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit.
    Vooturi S; Jayalakshmi S; Sahu S; Mohandas S
    Clin Neurol Neurosurg; 2014 Nov; 126():7-10. PubMed ID: 25194304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute seizure and status epilepticus in pediatric emergency.
    Sasidaran K; Singhi S; Singhi P
    Indian J Pediatr; 2012 Apr; 79(4):510-7. PubMed ID: 22120613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.